Subscribe To
Xilio Therapeutics to Present at the Guggenheim Healthcare Talks Oncology Day
WALTHAM, Mass., Feb. 02, 2023 (GLOBE NEWSWIRE) — Xilio Therapeutics, Inc. (Nasdaq: XLO), a biotechnology company developing tumor-activated immuno-oncology therapies for people living with cancer, today announced that René Russo, Pharm.D., chief executive officer, will participate in a fireside chat at the Guggenheim Healthcare Talks Oncology Day on Thursday, February 9, 2023, at 3:55 p.m. […] The post Xilio Therapeutics to Present at the Guggenheim Healthcare Talks Oncology Day appeared first o...
Read More
Posted: Feb 2 2023, 12:30
Author Name: forextv
Views: 102442